Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
411 studies found for:    Open Studies | Interventional Studies | melanoma
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | Interventional Studies | melanoma
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Ipilimumab and All-Trans Retinoic Acid Combination Treatment of Stage IV Melanoma
Condition: Melanoma
Interventions: Drug: All-Trans Retinoic Acid;   Drug: Ipilimumab
2 Recruiting A Clinical Trial of Patients With Melanoma
Condition: Melanoma
Interventions: Drug: Digoxin Combination;   Drug: Dabrafenib;   Drug: Trametinib
3 Recruiting A Phase I/II Trial of Vemurafenib and Metformin to Melanoma Patients
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Metformin
4 Recruiting Study Assessing Two Models of Hypofractionated Protontherapy on Large Choroidal Melanomas
Condition: Melanoma
Intervention: Radiation: Protontherapy
5 Recruiting A Phase 3 Study of Pembrolizumab + Epacadostat or Placebo in Subjects With Unresectable or Metastatic Melanoma (Keynote-252 / ECHO-301)
Condition: Melanoma
Interventions: Drug: pembrolizumab + epacadostat;   Drug: pembrolizumab + placebo
6 Not yet recruiting BGB324 in Combination With Pembrolizumab or Dabrafenib in Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: BGB324+pembrolizumab;   Drug: BGB324+dabrafenib;   Drug: pembrolizumab;   Drug: dabrafenib
7 Recruiting Treatment of Advanced Melanoma With MK-3475 and Peginterferon
Condition: Melanoma
Interventions: Drug: MK-3475;   Drug: Peginterferon alfa-2b
8 Recruiting Study of Dabrafenib, Trametinib and Metformin for Melanoma Patients
Condition: Melanoma
Interventions: Drug: Dabrafenib;   Drug: Trametinib;   Drug: Metformin
9 Recruiting A Tolerability and Pharmacokinetics Study of SHR6390 in Advanced Melanoma Patients
Condition: Melanoma
Intervention: Drug: SHR6390
10 Recruiting A Phase I Study With a Personalized NeoAntigen Cancer Vaccine in Melanoma
Condition: Melanoma
Interventions: Biological: Poly-ICLC;   Biological: Peptides
11 Recruiting Regorafenib, C-kit Mutated Malignant Melanoma, 2nd Line Therapy
Condition: Melanoma
Intervention: Drug: regorafenib
12 Recruiting Evaluating SINE KPT-330 in Treating Patients With Melanoma That Cannot Be Removed By Surgery
Condition: Recurrent Melanoma
Interventions: Drug: selinexor;   Other: Correlative studies
13 Recruiting A Clinical Trial of Adoptive Transfer With Autologous NKT Cells in Metastatic Melanoma Patients
Condition: Melanoma
Intervention: Biological: NKT cells
14 Recruiting PLX3397 KIT in Acral aNd mucOsal Melanoma
Condition: Malignant Melanoma
Intervention: Drug: PLX3397
15 Recruiting Phase I Clinical Trial of Tremelimumab Plus MEDI3617 in Patients With Unresectable Stage III or Stage IV Melanoma
Condition: Metastatic Melanoma
Interventions: Drug: Tremelimumab;   Drug: MEDI3617
16 Not yet recruiting Nivolumab Plus Radiotherapy in Advanced Melanoma
Condition: Melanoma
Interventions: Biological: Nivolumab;   Radiation: hypofractionned radiotherapy
17 Not yet recruiting Molecular Profiling and Matched Targeted Therapy for Patients With Metastatic Melanoma
Condition: Melanoma
Interventions: Drug: Standard therapy or clinical trial;   Drug: Matched targeted therapy;   Drug: Trametinib and / or supportive care
18 Recruiting The Effects of Vemurafenib + Cobimetinib on Immunity in Patients With Melanoma
Condition: Melanoma
Intervention: Drug: Vemurafenib
19 Recruiting Radiotherapy & Combi in Metastatic Melanoma
Condition: Metastatic Melanoma
Interventions: Radiation: Palliative radiotherapy;   Drug: Dabrafenib and trametinib (combination)
20 Recruiting Study of Neo-adjuvant Use of Vemurafenib Plus Cobimetinib for BRAF Mutant Melanoma With Palpable Lymph Node Metastases
Condition: Melanoma
Interventions: Drug: Vemurafenib;   Drug: Cobimetinib

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.